Reprogramming of myeloid cells of the tumor microenvironment increases the efficiency of CTLA-4 and PD-1 blockade in experimental malignant melanoma immunotherapy
Authors:
- A.V. PichuginAPA.V. Pichugin
- S.A. PodsvirovaSPS.A. Podsvirova
- E.I. UshakovaEUE.I. Ushakova
- D.M. SpirinDSD.M. Spirin
- E.S. LebedevaELE.S. Lebedeva
- R.I. AtaullakhanovRAR.I. Ataullakhanov
- M.V. Lomonosov Moscow State UniversityMUM.V. Lomonosov Moscow State University
- 1 January 2022
- journal article
- research article
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 43 (6)